Diane Elaine MacDougall

Title: Diane Elaine MacDougall: Innovator in Cardiovascular Treatments

Introduction

Diane Elaine MacDougall is a prominent inventor based in Lincoln, MA (US). She has made significant contributions to the field of cardiovascular disease treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on developing effective combinations of medications to improve patient outcomes.

Latest Patents

Diane's latest patents include groundbreaking formulations that combine ETC-1002 with ezetimibe. These compositions are designed to treat or reduce the risk of cardiovascular disease. The methods disclosed in her patents also address hypercholesterolemia, providing a comprehensive approach to managing cardiovascular health. Another notable patent involves fixed dose combinations of ETC-1002 and one or more statins, further enhancing treatment options for patients at risk of cardiovascular issues.

Career Highlights

Throughout her career, Diane has worked with notable companies, including Esperion Therapeutics, Inc. Her expertise in pharmacology and innovative formulations has positioned her as a leader in the development of cardiovascular therapies. Diane's contributions have been instrumental in advancing treatment methodologies and improving patient care.

Collaborations

Diane has collaborated with esteemed colleagues such as Roger Schofield Newton and Noah Laban Rosenberg. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of cardiovascular research.

Conclusion

Diane Elaine MacDougall's work exemplifies the impact of innovation in the medical field, particularly in the treatment of cardiovascular diseases. Her patents and collaborations highlight her commitment to improving health outcomes for patients. Diane continues to be a driving force in the development of effective therapeutic solutions.